“NASH or diabesity” (diabetes and/or obesity): which comes first?”

PRESENTERS DETAILS: 

Sven Francque, Professor, Department of Gastroenterology & Hepatology Antwerp University Hospital

Prof. Dr. Sven Francque obtained his MD at the University of Antwerp, Belgium, in 1994 and was subsequently trained in internal medicine and in gastroenterology and hepatology at the Antwerp University Hospital, Belgium and at the Department of Hepatology of the Beaujon hospital, Clichy, France. He has a long-standing interest and expertise in non-alcoholic fatty liver disease and conducted basic research focusing on the vascular changes in steatosis and their contribution to disease progression and leading to his PhD in 2011. His research unit continues to study pathophysiological mechanisms of NASH, with a sustained focus on vascular mechanisms in early NAFLD as well as on the adipose tissue-liver interaction. He is also conducting clinical research and his unit is partner in several research consortia supported by the European Commission and by the Innovative Medicines Initiative with a focus on NASH pathophysiology (with a focus on inter-organ cross-talk and the link with metabolism (especially PPARs), biomarker research and hepatocellular carcinoma. His clinical trial unit participates from the early days of clinical trials in NASH in many clinical trials in the field. Prof. Francque is a scientific committee member involved in the design of several phase 2 and current phase 3 trials in NAFLD and is national/international lead PI of several of these trials. He is also president of the scientific committee of the PanNASH Initiative and member of the scientific committee of the NASH Education Program. He is author/co-author of over 200 papers in peer-reviewed journals and authored several book chapters on NAFLD. He is editor of JHep Reports, the open-access journal of the European Association for the Study of the Liver. He is Educational Councillor-elect on the EASL Governing Board. He is senior clinical researcher for the Research Fund of the Flemish government. He is currently chairman of the Department of Gastroenterology and Hepatology of the University Hospital Antwerp and senior full professor of medicine at the Faculty of Medicine and Health Sciences of the University of Antwerp. He is scientific coordinator of the Belgian Week of Gastroenterology, the Belgian national gastroenterology and hepatology research meeting. He coordinated the Belgian guidelines on NAFLD and the EASL Patient NAFLD Guideline.

Chris Byrne, Professor, Faculty of Medicine, University of Southampton, UK

Chris Byrne trained as a physician-scientist in the UK and USA; at Cardiff, Cambridge and Stanford Universities undertaking a PhD studying liver lipid metabolism.
Chris Byrne is Professor of Endocrinology & Metabolism at the University of Southampton and Consultant Physician at University Hospital Southampton, with expertise in dyslipidaemias, metabolic liver disease and type 2 diabetes. Chris Byrne is a Principal Investigator within the Southampton National Institute for Health and Care Research (NIHR), Southampton Biomedical Research Centre. Chris Byrne was the UK Diabetologist advisor to the NICE non-alcoholic fatty liver disease (NAFLD) Guidelines (ng49) in 2016; and recipient of the Dorothy Hodgkin award in 2012 and the Banting Memorial lecture award in 2022 from Diabetes UK. The Banting Memorial Lecture is the highest award bestowed by Diabetes UK ‘to a person internationally recognised for their eminence in the field of diabetes’. In 2022 Chris Byrne was a ‘Clarivate’ ‘highly cited researcher’ (top 0.1% of global scientists) and in 2023 was ranked 5th by ‘Expertscape’ amongst global researchers for research output in NAFLD over the previous decade. Chris Byrne’s research (>450 peer-reviewed publications, including book chapters and three books) focusses on different aspects of NAFLD: including aetiology, pathogenesis, consequences and treatment.

Kenneth Cusi, M.D., F.A.C.P., F.A.C.E., Professor of Medicine Chief, Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville, USA

Dr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville (2011-present). He is also a faculty and researcher at the Endocrinology, Diabetes and Metabolism Division at the Veterans Administration Medical Center at Gainesville, Florida, USA

Jian-Gao Fan, MD, PhD, Professor and Director of Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Professor Jian-Gao Fan is Editor-in-Chief of Chinese Journal of Practical Hepatology, president of Committee on Fatty Liver Diseases, Chinese Physicians’ Association. He was co-chairman of Biennial Shanghai International Forum on Digestive Diseases between 2010-2022, and invited speaker in over 20 countries and regions.

The meeting is free to attend

Register Today